Table 1 Characteristics of the study population at the start of haemodialysis
Total | ||
|---|---|---|
N | % | |
Total | 3882 | |
Sex | ||
Male | 2588 | 66.7 |
Female | 1294 | 33.3 |
Age | ||
18–64 years | 1459 | 37.6 |
65 + years | 2423 | 62.4 |
Comorbidities | ||
Type 2 diabetes | 624 | 16.1 |
Hypertensive disease | 1390 | 35.8 |
Anaemias (excl. acute post-haemorrhagic) | 894 | 23 |
Ischemic heart disease | 502 | 12.9 |
Heart failure | 422 | 10.9 |
Cerebrovascular disease | 384 | 9.9 |
Conduction disorders, cardiac dysrhythmias | 313 | 8.1 |
Malignancies | 299 | 7.7 |
Chronic obstructive pulmonary disease | 204 | 5.3 |
Respiratory failure | 179 | 4.6 |
Disorders of lipoid metabolism | 160 | 4.1 |
Disorders of the thyroid gland | 142 | 3.7 |
Overweight, obesity and other hyperalimentation (BMI > 30) | 88 | 2.3 |
Chronic liver disease, diseases of the pancreas | 87 | 2.2 |
Peptic ulcer | 23 | 0.6 |
Dementias | 18 | 0.5 |
Mental disorders | 19 | 0.5 |
Nutritional deficiencies | 16 | 0.4 |
Chronic inflammatory intestinal diseases | 14 | 0.4 |